Discovery Lens
C Combination Innovation
Two separate worlds finally connect — and the intersection is a product
One-Liner
Automated reproducibility verification for lab protocols across EU Horizon-funded research networks, leveraging lab automation audit trails.
AI Thinking Process
EU Horizon-funded research networks are mandating Open Science and FAIR data principles — reproducibility of experimental protocols is a compliance requirement. Lab automation systems (Tecan, Hamilton, Beckman) generate detailed audit logs. Verb: use those audit logs to generate cross-lab reproducibility verification certificates for Horizon grant compliance.
Feature gate check: Benchling has 5,000+ academic and biotech lab customers with deep ELN integration — reproducibility verification is one product cycle away from their existing feature set. Altara: Greylock-backed, Jeff Dean seed investor, $7M raised, stated mission is exactly lab reproducibility and protocol verification. Two incumbents with superior credentials and existing customer bases.
KILLED: feature gate. Benchling absorbs in one product cycle. Altara is a funded direct competitor with better-credentialed founding team. Horizon funding signal is a market direction indicator, not a market gap indicator — Greylock saw the same signal and funded Altara.
Kill Reason
Benchling has 5,000+ academic and biotech labs as customers and is deploying foundation-model features quarterly — reproducibility verification is one product cycle away. Altara (Greylock and Jeff Dean seed, $7M) is racing toward the exact wedge with credentials a new entrant cannot match on day one.
Risk Analysis
Risk analysis available for latest engine ideas.
Loading...
Related ideas you can explore free:
killed: Passive voice-based depression detection requires FDA Software as a Medical Device clearance for any diagnostic claim; a "wellness" framing undercuts the core value proposition and reduces willingness to pay. Epic Systems and large telehealth platforms are already integrating validated mental health screening tools into clinical workflows, crowding out standalone apps before they achieve scale.
killed: Google Nest Hub's built-in Soli radar-based sleep sensing already delivers contactless respiratory monitoring in millions of households, and Withings has shipped FDA-cleared sleep apnea screening hardware. A standalone $30 WiFi module cannot match the distribution, brand trust, or regulatory standing of these well-resourced incumbents.
killed: Urine and stool analysis for glucose monitoring, cancer screening, and kidney function markers falls squarely into FDA Class II/III medical device territory, requiring clinical trials and 510(k) or PMA approval costing millions and taking years. The entire high-value use case — the reason anyone would buy this — is legally undeliverable without regulatory clearance the product cannot realistically obtain.